197 related articles for article (PubMed ID: 27646197)
1. Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.
Wardle MC; Vincent JN; Suchting R; Green CE; Lane SD; Schmitz JM
J Subst Abuse Treat; 2017 Jan; 72():32-39. PubMed ID: 27646197
[TBL] [Abstract][Full Text] [Related]
2. Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets.
Schmitz JM; Lindsay JA; Stotts AL; Green CE; Moeller FG
Exp Clin Psychopharmacol; 2010 Jun; 18(3):238-44. PubMed ID: 20545388
[TBL] [Abstract][Full Text] [Related]
3. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.
Schmitz JM; Mooney ME; Moeller FG; Stotts AL; Green C; Grabowski J
Drug Alcohol Depend; 2008 Apr; 94(1-3):142-50. PubMed ID: 18164144
[TBL] [Abstract][Full Text] [Related]
4. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
[TBL] [Abstract][Full Text] [Related]
5. A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence.
Carroll KM; Nich C; Petry NM; Eagan DA; Shi JM; Ball SA
Drug Alcohol Depend; 2016 Mar; 160():135-42. PubMed ID: 26817621
[TBL] [Abstract][Full Text] [Related]
6. Anhedonia in cocaine use disorder is associated with inflammatory gene expression.
Fries GR; Khan S; Stamatovich S; Dyukova E; Walss-Bass C; Lane SD; Schmitz JM; Wardle MC
PLoS One; 2018; 13(11):e0207231. PubMed ID: 30408130
[TBL] [Abstract][Full Text] [Related]
7. Deficits in consummatory reward relate to severity of cocaine use.
Wardle MC; Hoots JK; Miloslavich K; Nunez C; Dios C; Holden C; Ahluwahlia A; Green CE; Lane SD; Schmitz JM
Drug Alcohol Depend; 2023 Aug; 249():109950. PubMed ID: 37301068
[TBL] [Abstract][Full Text] [Related]
8. Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.
Yoon JH; Suchting R; McKay SA; San Miguel GG; Vujanovic AA; Stotts AL; Lane SD; Vincent JN; Weaver MF; Lin A; Schmitz JM
Psychol Addict Behav; 2020 Feb; 34(1):164-174. PubMed ID: 31233323
[TBL] [Abstract][Full Text] [Related]
9. The role of avoidance and inflexibility in characterizing response to contingency management for cocaine use disorders: A secondary profile analysis.
Stotts AL; Vujanovic A; Heads A; Suchting R; Green CE; Schmitz JM
Psychol Addict Behav; 2015 Jun; 29(2):408-13. PubMed ID: 25134057
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence.
Petitjean SA; Dürsteler-MacFarland KM; Krokar MC; Strasser J; Mueller SE; Degen B; Trombini MV; Vogel M; Walter M; Wiesbeck GA; Farronato NS
Drug Alcohol Depend; 2014 Dec; 145():94-100. PubMed ID: 25456571
[TBL] [Abstract][Full Text] [Related]
11. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
12. Objective and specific tracking of anhedonia via event-related potentials in individuals with cocaine use disorders.
Parvaz MA; Gabbay V; Malaker P; Goldstein RZ
Drug Alcohol Depend; 2016 Jul; 164():158-165. PubMed ID: 27226335
[TBL] [Abstract][Full Text] [Related]
13. Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
Bekhbat M; Li Z; Mehta ND; Treadway MT; Lucido MJ; Woolwine BJ; Haroon E; Miller AH; Felger JC
Mol Psychiatry; 2022 Oct; 27(10):4113-4121. PubMed ID: 35927580
[TBL] [Abstract][Full Text] [Related]
14. Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.
Crits-Christoph P; Wadden S; Gaines A; Rieger A; Gallop R; McKay JR; Gibbons MBC
J Subst Abuse Treat; 2018 Sep; 92():46-50. PubMed ID: 30032944
[TBL] [Abstract][Full Text] [Related]
15. A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence.
Farronato NS; Dürsteler-Macfarland KM; Wiesbeck GA; Petitjean SA
J Addict Dis; 2013; 32(3):274-87. PubMed ID: 24074193
[TBL] [Abstract][Full Text] [Related]
16. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T
JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Trial of Contingency Management for Smoking Cessation During Intensive Outpatient Alcohol Treatment.
Cooney JL; Cooper S; Grant C; Sevarino K; Krishnan-Sarin S; Gutierrez IA; Cooney NL
J Subst Abuse Treat; 2017 Jan; 72():89-96. PubMed ID: 27542442
[TBL] [Abstract][Full Text] [Related]
18. The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis.
Schmitz JM; Suchting R; Green CE; Webber HE; Vincent J; Moeller FG; Lane SD
Drug Alcohol Depend; 2021 Aug; 225():108800. PubMed ID: 34102508
[TBL] [Abstract][Full Text] [Related]
19. Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis.
Mancino MJ; McGaugh J; Feldman Z; Poling J; Oliveto A
Am J Addict; 2010; 19(2):169-77. PubMed ID: 20163389
[TBL] [Abstract][Full Text] [Related]
20. Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an
Shorter DI; Zhang X; Domingo CB; Nielsen EM; Kosten TR; Nielsen DA
Am J Drug Alcohol Abuse; 2020; 46(2):184-193. PubMed ID: 31914324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
